To empower scientists across the globe who are using CRISPR to improve the quality of life for all by providing key cornerstones of information and insight.
Thank you Cardea Bio for launching CRISPR QC to bring to market CRISPR quality control services to improve gene editing. With the BPU™ (Biosignal Process Unit) Platform and CRISPR-CHIP™ we look forward to helping organizations.#CRISPR#CRISPRQC#Cardea
We are thrilled to share that our CRISPR-Chip s now being showcased at the German DHMD Museum in Dresden. Seeing our innovative technology displayed alongside Watson and Crick's DNA model is truly an honor and a testament to the power of the CRISPR-Chip. https://t.co/Lugh0MChYj
Thrilled to have Zack Raborn, our VP of Operations, featured on the GenRAIT podcast! Discover how CRISPR-Cas9 is shaping the future of healthcare and the role of CRISPR QC in this exciting field.
Tune in here: https://t.co/pMvR1Y3lU2
#CRISPR#GeneEditing#PodcastInterview
Help us congratulate our co-founder, Kiana Aran, on being selected as one of @Inc's top female founders! This award is truly a testament to the impact our technology, the CRISPR-Chip, is making.
https://t.co/rthxbaVJsi
Great article from @GenomeWeb interviewing our CEO, Ross Bundy! The article goes over our past, present, and future – from the origins of our technology to our vision for the coming year.
https://t.co/6kUhlIpOsV
#CRISPR#crisprcas9#geneediting#agriculture#therapeutics
We're stepping into 2023 strong: we've just closed our seed round and added George Bonaros to our board of directors. Get all the details from the full press release below.
https://t.co/mlOTY8ak9B
🚨 APPLICATIONS OPEN 🚨
Are you doing research or building a business around CRISPR?
Apply for CRISPR QC's Innovator Award today!
We're giving away $3,500 in cash prizes, along with full access to our technology.
Don't miss out, submit now! → https://t.co/UEoxO8Nw87
Honored to have Dr. Kiana Aran and Dr. Paul Grint join our board.
Their demonstrated leadership is an invaluable asset to our growing team.
https://t.co/zTV2HiWD59
CRISPR QC selected as a SoCal "Cool Company"!
Come by our booth at 5-10-30 at Petco Park on the 28th to learn more about how we are building the standard by which CRISPR can deliver on it’s promise.
https://t.co/s1dqCfvsGT
We’re going to be at #FIVETENTHIRTY
April 28th 📆 Petco Park ⚾
@CONNECTinSD hosts San Diego's Innovation Day celebration💡
Learn More ➡️ https://t.co/blG35LBHnT
Serra Ventures is proud to have led the financing round for the CRISPR QC, a newly created entity based on @CardeaBio technology. Cardea has been a portfolio company of Serra since 2015.
https://t.co/rxWbYRWVfR
April 28th is the 1st San Diego Innovation Day - Celebrate at #FIVETENTHIRTY! 1500+ Attendees, 100+ Exhibitors, Class of 2022 Cool Companies, Games, Art, Pad Squad, and More!
🎟️ Learn More & Register
https://t.co/Gjs3GVisGD
Happy to announce the launch of @CrisprQc as a separate business using our CRISPR-chip™ technology for a range of QC services for CRISPR gene editing. A milestone in realizing real-world applications of our BPU™ Platform:
https://t.co/gRl0pU5876 #CRISPRQC#Cardea#CardeaBio
Thank you Cardea Bio for launching CRISPR QC to bring to market CRISPR quality control services to improve gene editing. With the BPU™ (Biosignal Process Unit) Platform and CRISPR-CHIP™ we look forward to helping organizations.#CRISPR#CRISPRQC#Cardea
Congratulations to Chief Science Officer of Cardea Bio Dr. Kiana Aran for receiving NIH funding to help set quality control standards for CRISPR therapies. We welcome her leadership and look forward to implementing her guidance. https://t.co/W0I9Hz3Smb